Making Meaningful Clinical Use of Biomarkers

Overview

Journal Biomark Insights

Publisher Sage Publications

Date 2017 Jun 30

PMID 28659713

Citations 69

Authors

Matthew J Selleck

Maheswari Senthil

Nathan R Wall

Affiliations

Soon will be listed here.

Abstract

This review discusses the current state of biomarker discovery for the purposes of diagnostics and therapeutic monitoring. We underscore relevant challenges that have defined the gap between biomarker discovery and meaningful clinical use. We highlight recent advancements in and propose a way to think about future biomarker development.

Citing Articles

Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights.

Rahdan F, Saberi A, Saraygord-Afshari N, Hadizadeh M, Fayeghi T, Ghanbari E Heliyon. 2024; 10(20):e39489.

PMID: 39498055 PMC: 11532857. DOI: 10.1016/j.heliyon.2024.e39489.

"My Biomarkers Are Fine, Thank You": On the Biomarkerization of Modern Medicine.

Hofmann B J Gen Intern Med. 2024; 40(2):453-457.

PMID: 39322866 PMC: 11803056. DOI: 10.1007/s11606-024-09019-8.

An original study assessing biomarker success rate in breast cancer recurrence biomarker research.

Savva K, MacKenzie A, Coombes R, Zhifang N, Hanna B, Peters C BMC Med. 2024; 22(1):307.

PMID: 39075505 PMC: 11288100. DOI: 10.1186/s12916-024-03460-6.

Unveiling Colorectal Cancer Biomarkers: Harnessing Biosensor Technology for Volatile Organic Compound Detection.

Golfinopoulou R, Hatziagapiou K, Mavrikou S, Kintzios S Sensors (Basel). 2024; 24(14).

PMID: 39066110 PMC: 11281049. DOI: 10.3390/s24144712.

Design, cohort profile and comparison of the KTD-Innov study: a prospective multidimensional biomarker validation study in kidney allograft rejection.

Goutaudier V, Sablik M, Racape M, Rousseau O, Audry B, Kamar N Eur J Epidemiol. 2024; 39(5):549-564.

PMID: 38625480 DOI: 10.1007/s10654-024-01112-w.

References

Carroll P, Vickers A . Point/Counterpoint: early detection of prostate cancer: do the benefits outweigh the consequences?. J Natl Compr Canc Netw. 2014; 12(5 Suppl):768-71. DOI: 10.6004/jnccn.2014.0186. View

Hagenbeek A, Gadeberg O, Johnson P, Moller Pedersen L, Walewski J, Hellmann A . First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial. Blood. 2008; 111(12):5486-95. DOI: 10.1182/blood-2007-10-117671. View

Khan S, Jutzy J, Aspe J, McGregor D, Neidigh J, Wall N . Survivin is released from cancer cells via exosomes. Apoptosis. 2010; 16(1):1-12. PMC: 3174681. DOI: 10.1007/s10495-010-0534-4. View

Jensen J, Heslet L, Jensen T, Espersen K, Steffensen P, Tvede M . Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med. 2006; 34(10):2596-602. DOI: 10.1097/01.CCM.0000239116.01855.61. View

Ichiki A, Krauss S, Israelsen K, Sonoda T, COLLMANN I . Sequential carcinoembryonic antigen levels. A predictor of response and relapse in combination chemotherapy of advanced gastrointestinal cancer. Oncology. 1981; 38(1):27-30. DOI: 10.1159/000225516. View

Scott S . Rituximab: a new therapeutic monoclonal antibody for non-Hodgkin's lymphoma. Cancer Pract. 1998; 6(3):195-7. DOI: 10.1046/j.1523-5394.1998.006003195.x. View

Kim J, Lee K, Lee J, Paik S, Rhee J, Choi K . Clinical usefulness of carbohydrate antigen 19-9 as a screening test for pancreatic cancer in an asymptomatic population. J Gastroenterol Hepatol. 2004; 19(2):182-6. DOI: 10.1111/j.1440-1746.2004.03219.x. View

Cardoso F, Costa A, Senkus E, Aapro M, Andre F, Barrios C . 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). Breast. 2016; 31:244-259. DOI: 10.1016/j.breast.2016.10.001. View

Cairoli R, Beghini A, Grillo G, Nadali G, Elice F, Ripamonti C . Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study. Blood. 2005; 107(9):3463-8. DOI: 10.1182/blood-2005-09-3640. View

10.

Burke H . Predicting Clinical Outcomes Using Molecular Biomarkers. Biomark Cancer. 2016; 8:89-99. PMC: 4896533. DOI: 10.4137/BIC.S33380. View

11.

Zhen C, Wang Y . Molecular monitoring of chronic myeloid leukemia: international standardization of BCR-ABL1 quantitation. J Mol Diagn. 2013; 15(5):556-64. DOI: 10.1016/j.jmoldx.2013.05.010. View

12.

Juweid M . Radioimmunotherapy of B-cell non-Hodgkin's lymphoma: from clinical trials to clinical practice. J Nucl Med. 2002; 43(11):1507-29. View

13.

Yim S, Chung Y . Reflections on the US FDA's Warning on Direct-to-Consumer Genetic Testing. Genomics Inform. 2015; 12(4):151-5. PMC: 4330248. DOI: 10.5808/GI.2014.12.4.151. View

14.

Hussaini M . Biomarkers in Hematological Malignancies: A Review of Molecular Testing in Hematopathology. Cancer Control. 2015; 22(2):158-66. DOI: 10.1177/107327481502200206. View

15.

Milinis K, Thornton M, Montazeri A, Rooney P . Adjuvant chemotherapy for rectal cancer: Is it needed?. World J Clin Oncol. 2015; 6(6):225-36. PMC: 4675908. DOI: 10.5306/wjco.v6.i6.225. View

16.

Obermeyer Z, Emanuel E . Predicting the Future - Big Data, Machine Learning, and Clinical Medicine. N Engl J Med. 2016; 375(13):1216-9. PMC: 5070532. DOI: 10.1056/NEJMp1606181. View

17.

Teutsch S, Bradley L, Palomaki G, Haddow J, Piper M, Calonge N . The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Initiative: methods of the EGAPP Working Group. Genet Med. 2008; 11(1):3-14. PMC: 2743609. DOI: 10.1097/GIM.0b013e318184137c. View

18.

States D, Omenn G, Blackwell T, Fermin D, Eng J, Speicher D . Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study. Nat Biotechnol. 2006; 24(3):333-8. DOI: 10.1038/nbt1183. View

19.

Lee H, Park S . Systemic Chemotherapy in Advanced Pancreatic Cancer. Gut Liver. 2016; 10(3):340-7. PMC: 4849685. DOI: 10.5009/gnl15465. View

20.

Michiels S, Ternes N, Rotolo F . Statistical controversies in clinical research: prognostic gene signatures are not (yet) useful in clinical practice. Ann Oncol. 2016; 27(12):2160-2167. PMC: 5178139. DOI: 10.1093/annonc/mdw307. View